MENU
GNLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Genelux (GNLX) Ownership - Who owns Genelux?
Genelux Corp is a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
2625 Townsgate Road
Phone
+1 805 267-9889
Employees
23
Web
https://www.genelux.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
134.47M
P/E Ratio
N/A
Total Cash
35.1M
Projected Growth
N/A
Total Debt
1.79M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.93
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GNLX
Capitalization
134M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
35.1M
Total Cash/Share
0.93
Total Debt
1.79M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
29.8M
P/B Ratio
5.63
Cash Flow
N/A
Earnings
-0.87
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
38K
Current Ratio
4.67
Current Revenue Per Employee
347.83
Dividends Per Share - Security
N/A
EBITDA
-28.78M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-92.71
Shares Held By Institutions
23M
Shares Outstanding - Current
37.8M
Total Liabilities
9.14M
Total Volume MTD
N/A
Value
-1
Gain YTD
50.847
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GNLX showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2625 Townsgate Road
Phone
+1 805 267-9889
Employees
23
Web
https://www.genelux.com